People with type 2 diabetes who stop taking GLP-1 receptor agonist medicines may have higher rates of cardiovascular events and death than those who remain on treatment, according to a large Italian ...
Personalised health coaching delivered through a smartphone app may help reduce the likelihood of developing gestational ...
Persistently elevated HbA1c was associated with a substantially greater risk of developing diabetic neuropathy, according to ...
Tirzepatide is the active ingredient in Mounjaro, a medicine already used in adults for type 2 diabetes and weight management ...
People exposed to sugar rationing during more of their first 1,000 days showed lower biological-age acceleration in later ...
Annette Quilter, a 42-year-old GP from Shropshire, is the first UK patient to receive teplizumab following its approval for ...
A review of 40 observational studies found that type 2 diabetes was associated with a 53% higher relative risk of Alzheimer’s disease. Researchers estimated approximately 4.7 new Alzheimer’s diagnoses ...
Intensive treatment was associated with a smaller increase in white-matter brain lesions, although the clinical significance ...
A major international study involving more than 844,000 adults suggests that relying on body mass index (BMI) alone may leave ...
A relatively inexpensive blood test could become an important first step in identifying serious liver disease among people with obesity and type 2 diabetes, according to research published in The ...
Cleaner bedroom air may help stabilise glucose in people with prediabetes, according to results presented at a major ...
Resistance exercise could help address concerns about muscle loss during treatment with tirzepatide, according to a randomised clinical trial. Researchers recruited 120 adults living with overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results